Up to $20 million grant available; Letter of Intent deadline is Nov. 5, 2014PHILADELPHIA—- September 18, 2014 — The American Association for Cancer Research (AACR) is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-American Cancer Society Lung Cancer Translational Research Dream Team Grant that will offer up to $20 million in research funding, with the Society and SU2C each providing half the funds over a three-year period. Bristol-Myers Squibb will provide funding in the amount of $5 million to SU2C that will support this Dream Team.
The grant provides funding for research projects that must include therapeutic interventions for lung cancer and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional Dream Team of experts. The research will be expected to involve new immunological approaches. Proposals for the grant must describe plans indicating how the group will use a transformative and synergistic approach, and how the work will be translated into the clinic. To maximize creativity, innovation, and collaboration, the projects should span multiple disciplines and use modern scientific tools to attack research questions in a coordinated effort.
A SU2C-American Cancer Society Joint Scientific Advisory Committee (JSAC) will conduct a unique, interactive, rapid, and rigorous evaluation of the applications via a multistep scientific review process. The JSAC is comprised of highly accomplished senior laboratory researchers and physician-scientists, as well as advocates.
The committee is chaired by Nobel Laureate Phillip A. Sharp, PhD, institute professor at the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology in Cambridge. Arnold J. Levine, PhD, professor at the Institute for Advanced Study in Princeton, New Jersey, and at the Cancer Institute of New Jersey in New Brunswick, and William H. Chambers, PhD, national vice president, extramural research, at the American Cancer Society will serve as vice-chairs.
Letters of Intent for the SU2C-ACS Lung Cancer Translational Research Dream Team Grant are due by noon ET, Nov. 5, 2014, via proposalCENTRAL at https://proposalcentral.altum.com/default.asp?GMID=39
For general information on eligibility criteria, the application process, and other details about Dream Team grants, visit http://www.aacr.org/su2cfunding/dreamteam
Inquiries may be directed to the AACR Scientific Review and Grants Administration Department at 267-765-1049 or su2c@aacr.org.
The SU2C-American Cancer Society Lung Cancer Translational Research Dream Team Grant recipients are scheduled to be announced in spring 2015.
# # #Media Contacts:
SU2C
Jane Rubinstein
646-386-7969
jrubinstein@eifoundation.org
AACR
Rick Buck
215-446-7162
rick.buck@aacr.org
American Cancer Society
David Sampson
213-407-9950
david.sampson@cancer.org
About Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry’s resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about progress being made in the fight against the disease. As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, Ph.D., conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.
Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. All current members of the CFA were co-producers of the 2012 and 2014 televised specials. The late co-founder Laura Ziskin executive produced both the Sept. 5, 2008, and Sept. 10, 2010, broadcasts. SU2C was formally launched on May 27, 2008. Sung Poblete, Ph.D., R.N., has served as SU2C’s president and CEO since 2011.
For more information on Stand Up To Cancer visit http://www.standup2cancer.org.
About The American Cancer Society
The American Cancer Society is a global grassroots force of more than three million volunteers saving lives and fighting for every birthday threatened by every cancer in every community. As the largest voluntary health organization, the Society’s efforts have contributed to a 20 percent decline in cancer death rates in the U.S. since 1991, and a 50 percent drop in smoking rates. Thanks in part to our progress nearly 14 million Americans who have had cancer and countless more who have avoided it will celebrate more birthdays this year. As we celebrate 100 years of service, we’re determined to finish the fight against cancer. We’re finding cures as the nation’s largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings, clean air, and more. For more information, to get help, or to join the fight, call us anytime, day or night, at 1-800-227-2345 or visit http://www.cancer.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in 97 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with over 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org.